Sax Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.41M Buy
1,529
+757
+98% +$773K 0.06% 185
2026
Q1
$830K Sell
772
-150
-16% -$152K 0.04% 219
2025
Q4
$991K Buy
922
+26
+3% +$24.9K 0.05% 205
2025
Q3
$684K Buy
896
+207
+30% +$154K 0.04% 226
2025
Q2
$537K Buy
689
+86
+14% +$66.8K 0.03% 246
2025
Q1
$498K Buy
603
+235
+64% +$196K 0.04% 223
2024
Q4
$284K Buy
368
+13
+4% +$10.8K 0.02% 275
2024
Q3
$315K Sell
355
-6
-2% -$5.39K 0.03% 217
2024
Q2
$327K Buy
+361
New +$289K 0.03% 199
2024
Q1
Sell
-365
Closed -$213K 210
2023
Q4
$213K Buy
+365
New +$213K 0.03% 180

Other funds holding LLY

Sax Wealth Advisors's LLY Position: Q2 2026 in Review

Sax Wealth Advisors increased its Eli Lilly (LLY) stake by 98% in Q2 2026, buying an estimated $773K and bringing the position to 1,529 shares worth $1.41M. The position accounts for 0.06% of the portfolio, ranked #185.

Sax Wealth Advisors first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. 1,125 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Sax Wealth Advisors held 1,529 shares of Eli Lilly worth $1.41M as of Q2 2026.
  • Sax Wealth Advisors bought 757 Eli Lilly shares in Q2 2026, an estimated $773K.
  • Eli Lilly made up 0.06% of Sax Wealth Advisors's portfolio in Q2 2026, its #185 holding.
  • Sax Wealth Advisors first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • 1,125 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Sax Wealth Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.